Tofacitinib therapy is being studied (not yet approved) in several dermatologic conditions - psoriasis, alopecia areata/universalis, vitiligo, atopic dermatitis and dermatomyositis. https://t.co/Ez3u95Eh7K
Links:
Oral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology. - PubMed -…
https://buff.ly/2mV70Ur
Sep-30-2019
